BioSolution and Merck Life Science Unveil Animal‑Free Testing Solution at CPHI Korea 2026

BioSolution announced a collaboration with global life‑science company Merck Life Science to introduce an animal‑alternative testing research solution that integrates 3D human tissue models with precise analytical technology. The joint booth will be presented at the World Pharma·Bio·Health Functional Industry Exhibition (CPHI Korea 2026) held from May 25‑27 at COEX, Seoul. The exhibitors will demonstrate a complete workflow that links both technologies into a single research process, enabling the use of the combined platform for animal‑free testing, a growing demand in new‑drug and cosmetics development.